• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    Mar 03, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Drugs for neglected diseases: a failure of the market and a public health failure?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Access Trouiller TMIH 2001.pdf
    Size:
    134.2Kb
    Format:
    PDF
    Download
    Authors
    Trouiller, P
    Torreele, E
    Olliaro, P
    White, N J J
    Foster, S
    Wirth, D
    Pécoul, B
    Affiliation
    Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
    Issue Date
    2001-11
    
    Metadata
    Show full item record
    Journal
    Tropical Medicine & International Health
    Abstract
    Infectious diseases cause the suffering of hundreds of millions of people, especially in tropical and subtropical areas. Effective, affordable and easy-to-use medicines to fight these diseases are nearly absent. Although science and technology are sufficiently advanced to provide the necessary medicines, very few new drugs are being developed. However, drug discovery is not the major bottleneck. Today's R&D-based pharmaceutical industry is reluctant to invest in the development of drugs to treat the major diseases of the poor, because return on investment cannot be guaranteed. With national and international politics supporting a free market-based world order, financial opportunities rather than global health needs guide the direction of new drug development. Can we accept that the dearth of effective drugs for diseases that mainly affect the poor is simply the sad but inevitable consequence of a global market economy? Or is it a massive public health failure, and a failure to direct economic development for the benefit of society? An urgent reorientation of priorities in drug development and health policy is needed. The pharmaceutical industry must contribute to this effort, but national and international policies need to direct the global economy to address the true health needs of society. This requires political will, a strong commitment to prioritize health considerations over economic interests, and the enforcement of regulations and other mechanisms to stimulate essential drug development. New and creative strategies involving both the public and the private sector are needed to ensure that affordable medicines for today's neglected diseases are developed. Priority action areas include advocating an essential medicines R&D agenda, capacity-building in and technology transfer to developing countries, elaborating an adapted legal and regulatory framework, prioritizing funding for essential drug development and securing availability, accessibility, distribution and rational use of these drugs.
    Publisher
    Wiley-Blackwell
    URI
    http://hdl.handle.net/10144/28439
    PubMed ID
    11703850
    Language
    en
    ISSN
    1360-2276
    Collections
    Health Politics

    entitlement

    Related articles

    • Towards a higher priority for health on the development agenda.
    • Authors: Yach D, von Schirnding YE
    • Issue date: 1994
    • Drug development for neglected diseases: a deficient market and a public-health policy failure.
    • Authors: Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N
    • Issue date: 2002 Jun 22
    • Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    • Authors: Suleman S, Woliyi A, Woldemichael K, Tushune K, Duchateau L, Degroote A, Vancauwenberghe R, Bracke N, De Spiegeleer B
    • Issue date: 2016 May
    • Primary health care: from aspiration to achievement.
    • Authors: Diallo I, Molouba R, Sarr LC
    • Issue date: 1993
    • [An analysis of the pharmaceuticals market in Vietnam].
    • Authors: Simonet D
    • Issue date: 2001 Jul-Sep
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.